Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone effect on airway resistance in congestive heart failure
IRCT201104196231N1Phase 2Completed
- Sponsor
- Mostafa Science and Technology Foundation
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone in heart failure (HF), sponsored by Mostafa Science and Technology Foundation. Primary endpoint: Change in airway resistance measured by impulse oscillometry. Started Jan 2011; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT201104196231N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201104196231N1.